A virtual national laboratory for reengineering clinical translational science.
A virtual national laboratory for reengineering clinical translational science.
复制标题
DOI:
10.1126/scitranslmed.3002951
复制
发表时间:
2012-01-25
影响因子:
17.1
通讯作者:
Trochim WM
中科院分区:
文献类型:
--
作者:
Dilts DM;Rosenblum D;Trochim WM
Clinical research is burdened by complex pathways, tedious steps, numerous inefficiencies, and a poor track record of trial completion. The CTSA Program’s consortium supports a unified national effort that has become, in effect, a virtual national laboratory designed to identify, implement, evaluate, and continue process improvement across all the steps required to design, approve, initiate, and complete clinical trials. If it is properly supported by academic centers, industry, and funding agencies, the virtual national laboratory could succeed in advancing and maintaining major improvements in clinical trial conduct and efficiency.
登录
查看更多内容
影响因子:
45.3
作者:
Korn, Edward L.;Freidlin, Boris;Abrams, Jeffrey S.
通讯作者:
Abrams, Jeffrey S.
影响因子:
17.1
作者:
Collins, Francis S.
通讯作者:
Collins, Francis S.
DOI:
10.1158/1078-0432.ccr-10-0133
发表时间:
2010-11-15
期刊:
Clinical cancer research : an official journal of the American Association for Cancer Research
影响因子:
--
作者:
Cheng SK;Dietrich MS;Dilts DM
通讯作者:
Dilts DM
影响因子:
3.9
作者:
Trochim, William;Kane, Cathleen;Pincus, Harold A.
通讯作者:
Pincus, Harold A.
影响因子:
3.5
作者:
DiMasi, JA;Hansen, RW;Grabowski, HG
通讯作者:
Grabowski, HG